Ueno, Ryuji

Clinical trial: lubiprostone in patients with constipation‐associated irritable bowel syndrome – results of two randomized, placebo‐controlled studies

DROSSMAN, D. A., CHEY, W. D., JOHANSON, J. F., FASS, R., SCOTT, C., PANAS, R., & UENO, R. (2009) · Alimentary Pharmacology & Therapeutics

Gastrointestinal motility and disordersInflammatory Bowel Disease

Cited by 399

Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation

Johanson, J. F., Morton, D., Geenen, J., & Ueno, R. (2008) · The American Journal of Gastroenterology

Gastrointestinal motility and disordersPelvic floor disorders treatments

Cited by 331

Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers

Camilleri, M., Bharucha, A. E., Ueno, R., Burton, D., Thomforde, G. M., Baxter, K., McKinzie, S., & Zinsmeister, A. R. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology

Gastrointestinal motility and disordersIon Transport and Channel Regulation

Cited by 253

Efficacy and safety of lubiprostone in patients with chronic constipation

Barish, C. F., Drossman, D., Johanson, J. F., & Ueno, R. (2010) · Digestive Diseases and Sciences

Gastrointestinal motility and disordersPelvic floor disorders treatments

Cited by 192

Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation

Fukudo, S., Hongo, M., Kaneko, H., Takano, M., & Ueno, R. (2015) · Clinical Gastroenterology and Hepatology

Gastrointestinal motility and disordersPelvic floor disorders treatments

Cited by 110

Awaking effect of PGE2 microinjected into the preoptic area of rats

Matsumura, H., Goh, Y., Ueno, R., Sakai, T., & Hayashi, O. (1988) · Brain Research

Sleep and Wakefulness ResearchCircadian rhythm and melatonin

Cited by 46